Tonsillectomy with steroid pulse: a curative therapy for IgA nephropathy

Area of Science:

• Nephrology
• Immunology

Background:

• IgA nephropathy (IgAN) is a leading cause of end-stage renal disease (ESRD).
• Traditionally considered incurable, IgAN management focused on slowing progression.

Discussion:

• Combined tonsillectomy with steroid pulse (TS) therapy shows promise for IgAN remission.
• Treatment efficacy is stage-dependent, with early intervention yielding better results.
• The management paradigm is shifting from delaying ESRD to achieving clinical remission.

Key Insights:

• Early-stage IgAN patients can achieve clinical remission with TS therapy.
• Advanced disease or prolonged duration reduces treatment effectiveness.
• The principle for initiating TS therapy is 'the earlier, the better'.

Outlook:

• This shift signifies a move towards proactive, remission-focused IgAN treatment.
• Further research may explore optimal timing and patient selection for TS therapy.
• Potential for improved long-term outcomes in IgAN patients.